๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
41.25
-5.40 (-11.58%)
At close: Nov 20, 2026

Pet Pharm Biotech Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
266.86222.03130.7117.8775.74
Revenue Growth
40.06%69.88%10.89%55.62%-
Gross Profit
138.34116.4469.9664.5935.86
Operating Income
23.7814.748.117.59-4.84
Net Income
47.4524.9914.519.15-3.81
Earnings Per Share
0.810.450.350.30-0.16
EPS Growth
87.02%28.44%17.07%--

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
205.4518.86387.93168.4916.76
Total Debt
122.3106.16143.8848.242.52
Net Cash (Debt)
83.1412.7244.05120.29-25.77
Net Cash Growth
-79.86%69.11%102.89%--
Net Cash Per Share
1.427.545.903.99-1.02

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
95.4734.328.8820.75-17.83
Capital Expenditures
41.94-29.51-188.4-12.68-10.04
Free Cash Flow
137.414.79-159.518.08-27.87
Free Cash Flow Growth
-----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
51.84%52.44%53.53%54.80%47.34%
Operating Margin
8.91%6.64%6.21%6.44%-6.39%
Pretax Margin
17.46%10.89%9.50%7.76%-5.03%
Profit Margin
17.78%11.25%11.10%7.76%-5.03%
FCF Margin
51.49%2.16%-122.05%6.85%-36.80%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingNov '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
0.2460.2460.0890.194
Dividend Per Share Growth
183.61%177.68%-54.37%-
Dividend Yield
0.60%0.40%0.22%-

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
51.10143.47114.14--
P/FCF Ratio
19.72748.49---
PS Ratio
10.1616.1412.67--